Abstract: Oral dosage forms comprising Cefixime Trihydrate and at least one pharmaceutically acceptable excipient(s), wherein more than 60% of the Cefixime particles are smaller than 20μ or 95% of Cefixime particles are above 250μ is disclosed herein.
| # | Name | Date |
|---|---|---|
| 1 | 1843-MUM-2009- CORRESPONDENCE (07-12-2011).pdf | 2011-12-07 |
| 1 | 1843-mum-2009-abstract(10-8-2010).doc | 2018-08-10 |
| 2 | 1843-MUM-2009-ABSTRACT(10-8-2010).pdf | 2018-08-10 |
| 2 | 1988-MUM-2009-FORM 18(14-12-2011).pdf | 2011-12-14 |
| 3 | 1988-MUM-2009-CORRESPONDENCE(14-12-2011).pdf | 2011-12-14 |
| 4 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(FER)-(27-10-2014).pdf | 2014-10-27 |
| 4 | 1843-MUM-2009-CLAIMS(10-8-2010).pdf | 2018-08-10 |
| 5 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(AB21)-(28-10-2015).pdf | 2015-10-28 |
| 5 | 1843-MUM-2009-CORRESPONDENCE(10-8-2010).pdf | 2018-08-10 |
| 6 | 1843-MUM-2009_EXAMREPORT.pdf | 2018-08-10 |
| 6 | 1843-MUM-2009-CORRESPONDENCE(25-8-2009).pdf | 2018-08-10 |
| 7 | 1843-MUM-2009-FORM 5(10-8-2010).pdf | 2018-08-10 |
| 7 | 1843-MUM-2009-CORRESPONDENCE(8-3-2013).pdf | 2018-08-10 |
| 8 | 1843-mum-2009-form 3.pdf | 2018-08-10 |
| 8 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(7-11-2010).pdf | 2018-08-10 |
| 9 | 1843-mum-2009-correspondence.pdf | 2018-08-10 |
| 9 | 1843-mum-2009-form 26.pdf | 2018-08-10 |
| 10 | 1843-MUM-2009-DESCRIPTION(COMPLETE)-(10-8-2010).pdf | 2018-08-10 |
| 10 | 1843-mum-2009-form 2.pdf | 2018-08-10 |
| 12 | 1843-mum-2009-description(provisional).pdf | 2018-08-10 |
| 12 | 1843-mum-2009-form 2(title page).pdf | 2018-08-10 |
| 13 | 1843-MUM-2009-FORM 1(25-8-2009).pdf | 2018-08-10 |
| 13 | 1843-MUM-2009-FORM 2(TITLE PAGE)-(10-8-2010).pdf | 2018-08-10 |
| 14 | 1843-mum-2009-form 1.pdf | 2018-08-10 |
| 14 | 1843-mum-2009-form 2(10-8-2010).pdf | 2018-08-10 |
| 16 | 1843-mum-2009-form 1.pdf | 2018-08-10 |
| 16 | 1843-mum-2009-form 2(10-8-2010).pdf | 2018-08-10 |
| 17 | 1843-MUM-2009-FORM 1(25-8-2009).pdf | 2018-08-10 |
| 17 | 1843-MUM-2009-FORM 2(TITLE PAGE)-(10-8-2010).pdf | 2018-08-10 |
| 18 | 1843-mum-2009-description(provisional).pdf | 2018-08-10 |
| 18 | 1843-mum-2009-form 2(title page).pdf | 2018-08-10 |
| 20 | 1843-MUM-2009-DESCRIPTION(COMPLETE)-(10-8-2010).pdf | 2018-08-10 |
| 20 | 1843-mum-2009-form 2.pdf | 2018-08-10 |
| 21 | 1843-mum-2009-correspondence.pdf | 2018-08-10 |
| 21 | 1843-mum-2009-form 26.pdf | 2018-08-10 |
| 22 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(7-11-2010).pdf | 2018-08-10 |
| 22 | 1843-mum-2009-form 3.pdf | 2018-08-10 |
| 23 | 1843-MUM-2009-CORRESPONDENCE(8-3-2013).pdf | 2018-08-10 |
| 23 | 1843-MUM-2009-FORM 5(10-8-2010).pdf | 2018-08-10 |
| 24 | 1843-MUM-2009-CORRESPONDENCE(25-8-2009).pdf | 2018-08-10 |
| 24 | 1843-MUM-2009_EXAMREPORT.pdf | 2018-08-10 |
| 25 | 1843-MUM-2009-CORRESPONDENCE(10-8-2010).pdf | 2018-08-10 |
| 25 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(AB21)-(28-10-2015).pdf | 2015-10-28 |
| 26 | 1843-MUM-2009-CORRESPONDENCE(IPO)-(FER)-(27-10-2014).pdf | 2014-10-27 |
| 26 | 1843-MUM-2009-CLAIMS(10-8-2010).pdf | 2018-08-10 |
| 27 | 1988-MUM-2009-CORRESPONDENCE(14-12-2011).pdf | 2011-12-14 |
| 28 | 1988-MUM-2009-FORM 18(14-12-2011).pdf | 2011-12-14 |
| 28 | 1843-MUM-2009-ABSTRACT(10-8-2010).pdf | 2018-08-10 |
| 29 | 1843-MUM-2009- CORRESPONDENCE (07-12-2011).pdf | 2011-12-07 |